PRINCIPAL FINANCIAL GROUP INC - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$91,176
-5.6%
30,392
+17.7%
0.00%
Q2 2023$96,559
+29.9%
25,818
+16.3%
0.00%
Q1 2023$74,343
-20.9%
22,192
+13.5%
0.00%
Q4 2022$94,026
-6.0%
19,548
+11.7%
0.00%
Q3 2022$100,000
+6.4%
17,507
+31.4%
0.00%
Q2 2022$94,000
-55.9%
13,326
+119.2%
0.00%
Q3 2021$213,0006,0800.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 1,260,000$3,780,00035.90%
BML Capital Management, LLC 4,800,000$14,400,00013.22%
Stonepine Capital Management, LLC 1,720,000$5,160,0001.71%
TANG CAPITAL MANAGEMENT LLC 3,600,000$10,800,0001.52%
CM Management, LLC 275,000$825,0000.88%
Bain Capital Life Sciences Investors, LLC 2,485,638$7,456,9140.83%
EcoR1 Capital, LLC 6,995,861$20,987,5830.71%
SECTORAL ASSET MANAGEMENT INC 600,461$1,801,3830.35%
Newtyn Management, LLC 400,000$1,200,0000.30%
Diametric Capital, LP 200,000$600,0000.25%
View complete list of ATEA PHARMACEUTICALS INC shareholders